idarubicin has been researched along with mefloquine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bach, J; Eagon, S; Everson, N; Falade, MO; Guy, RK; Hammill, JT; Rice, AL | 1 |
| DiBernardo, C; Eagon, S; Falade, MO; Fitzsimmons, K; Glidden, JE; Guy, RK; Hammill, JT; Kimball, JJ; Law, J; Manjunath, A; Nguyen, B; Rice, AL; Sienko, N; Thompson, K; Wilkinson, SP | 1 |
1 review(s) available for idarubicin and mefloquine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for idarubicin and mefloquine
| Article | Year |
|---|---|
Identification of Plasmodium falciparum heat shock 90 inhibitors via molecular docking.
Topics: Antimalarials; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Fibroblasts; HSP90 Heat-Shock Proteins; Humans; Molecular Docking Simulation; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2021 |
Antimalarial activity of 2,6-dibenzylidenecyclohexanone derivatives.
Topics: Antimalarials; Cell Proliferation; Chloroquine; Dose-Response Relationship, Drug; Fibroblasts; Humans; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2021 |